Mark PRUZANSKI

Total number of appointments 1

• Date of birth: November 1967

INTERCEPT PHARMA EUROPE LTD. (09224395)

• Company status: Active
• Correspondence address: One, Glass Wharf, Bristol, United Kingdom, BS2 0ZX
• Role (Resigned): Director
• Appointed on: 19 August 2015
• Resigned on: 1 January 2021
• Nationality: Canadian
• Country of residence: United States
• Occupation: Ceo & President